Prevention of Childhood Maltreatment in Families With Young Children

July 30, 2023 updated by: Bradley Hospital

Embedding Mental Health Consultation Within Prenatal Home Visiting to Prevent Child Maltreatment and Violence Exposure

This study will examine the efficacy of Enhanced First Connections, which is a short-term perinatal home visiting program that includes infant and early childhood mental health consultation. Mothers with a history of adversity or trauma will be the focus of this research. Hypothesized outcomes of Enhanced First Connections include the prevention of child maltreatment (child abuse and neglect), prevention of child exposure to adult intimate partner violence, increases in family engagement in longer-term evidence based home visiting programs, increases in family engagement in specialized support services to address maternal adversity and trauma, reductions in maternal risk factors, and the promotion of positive parenting and the parent-child relationship.

Study Overview

Status

Enrolling by invitation

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhode Island
      • East Providence, Rhode Island, United States, 02915
        • E.P. Bradley Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Pregnant women
  • Recruited in the second or third trimester of pregnancy
  • Eligible for the Supplemental Nutrition Program for Women, Infants, and Children (WIC)
  • At least one self-reported experience of adversity or trauma
  • English or Spanish speaking

Exclusion Criteria:

- Does not meet all inclusion criteria above

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Enhanced First Connections
Enhanced First Connections is a short-term risk assessment and response home visiting referral program. The goal of Enhanced First Connections is to identify family needs and link families to community resources, including evidence based home visiting models. Enhanced First Connections includes prenatal identification and engagement of women with an adversity or trauma history, and infant and early childhood mental health consultation. Women who enroll in Enhanced First Connections are expected to receive between four and eight home visits before being referred to other community resources.
Enhanced First Connections is a short-term home visiting program that includes prenatal identification and engagement of women with an adversity or trauma history, and infant and early childhood mental health consultation.
No Intervention: Treatment as Usual
Women who receive Treatment as Usual will follow the usual course of clinical care throughout their pregnancy and into the postpartum period, and will be eligible for the typical array of community services that may be offered to them.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child Maltreatment Status
Time Frame: 6-months postpartum
Child protection record review
6-months postpartum
Child Exposure to Intimate Partner Violence
Time Frame: 6-months postpartum
Child protection record review
6-months postpartum
Maternal Report of Intimate Partner Violence
Time Frame: 6-months postpartum
Maternal report: Conflict Tactics Scales
6-months postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family engagement in evidence based home visiting programs
Time Frame: 6-months postpartum
Home visiting record review
6-months postpartum
Contextual stress exposure
Time Frame: 6-months postpartum
Maternal report: Contextual Stress Interview
6-months postpartum
Maternal depressive symptoms
Time Frame: 6-months postpartum
Maternal report: Patient Health Questionnaire-9
6-months postpartum
Maternal anxiety symptoms
Time Frame: 6-months postpartum
Maternal report: Generalized Anxiety Disorder 7-item scale
6-months postpartum
Maternal PTSD symptoms
Time Frame: 6-months postpartum
Maternal report: Short Post-Traumatic Stress Disorder Rating Interview
6-months postpartum
Maternal alcohol use
Time Frame: 6-months postpartum
Maternal report: Alcohol Use Disorders Test
6-months postpartum
Maternal substance use
Time Frame: 6-months postpartum
Maternal report: Drug Abuse Screening Test
6-months postpartum
Maternal parenting stress
Time Frame: 6-months postpartum
Maternal report: Parenting Stress Index
6-months postpartum
Maternal sensitivity
Time Frame: 6-months postpartum
Observation of free play interaction coded using Parent Caregiver Involvement Scales and Emotional Availability Scales
6-months postpartum
Maternal hostility
Time Frame: 6-months postpartum
Observation of free play interaction coded using Emotional Availability Scales
6-months postpartum
Maternal non-responsiveness
Time Frame: 6-months postpartum
Maternal report: Maternal Responsiveness Questionnaire
6-months postpartum
Home environment
Time Frame: 6-months postpartum
Home Observation for Measurement of the Environment
6-months postpartum
Mother-infant relationship
Time Frame: 6-months postpartum
Maternal report: Postpartum Bonding Questionnaire
6-months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie H Parade, PhD, E.P. Bradley Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 22, 2021

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

April 6, 2020

First Submitted That Met QC Criteria

April 8, 2020

First Posted (Actual)

April 10, 2020

Study Record Updates

Last Update Posted (Actual)

August 1, 2023

Last Update Submitted That Met QC Criteria

July 30, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • R01CE003103 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Final datasets generated from questionnaire, interview, and observational assessments will be cleaned and merged using SPSS syntax to generate a final dataset for analysis. A public use de-identified dataset that does not include sensitive or potentially identifiable information will be made available. For datasets that include sensitive or potentially identifiable information, data-use agreements will be put in place with appropriate restrictions prior to the provision of data. To ensure that released data have appropriate documentation, a data dictionary will accompany all de-identified datasets that includes data collection methods, measures and variable construction, and potential limitations of use.

IPD Sharing Time Frame

A de-identified dataset will be made available within 30 months following completion of the project or at the time of the publication of manuscripts that present the main aims of the study

IPD Sharing Access Criteria

A public use de-identified dataset that does not include sensitive or potentially identifiable information will be made broadly available. For datasets that include sensitive or potentially identifiable information, data-use agreements will be put in place with appropriate restrictions prior to the provision of data.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Maltreatment

Clinical Trials on Enhanced First Connections

3
Subscribe